ETF & Funds ceased circulation
Fonds négociés en bourse (FNB)
Type de fonds
BMO Global Asset Management
Fournisseur
-
valeur liquidative par action
20/01/2021
Date de lancement
1 fois par an
Paiement de dividendes
Equity
Objet d'investissement
MSCI ACWI IMI Genomic Innovation Index
Benchmark
0.45 %
Ratio de coût total
2,93 mln CAD
Actif total du fonds | 05/12/2023
2,93 mln CAD
Volume des actits de classe "actions" | 05/12/2023
Dernières données pour
Dernières données pour 05/12/2023
The BMO MSCI Genomic Innovation Index ETF has been designed to replicate, to the extent possible, the performance of the MSCI ACWI IMI Genomic Innovation Index, net of expenses. The Fund captures this mega trend by investing in stocks that have high exposure to innovative genomic companies.
The BMO MSCI Genomic Innovation Index ETF (CAD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in Global. The BMO Global Asset Management fund’s base currency is CAD and the share class was registered 20.01.2021 with unique ISIN - CA05591N1033. The total expense ratio is 0.45%. The BMO MSCI Genomic Innovation Index ETF (CAD) pays dividends 1 time(s) per year.